The Ontario government is expanding its Respiratory Syncytial Virus (RSV) immunization program this fall to include all residents aged 75 and older, aiming to protect seniors and reduce hospitalizations during the respiratory illness season.
The expansion builds on last year’s program, which already included high-risk adults aged 60 to 74, infants up to eight months in their first RSV season, and high-risk children up to 24 months in their second season. Pregnant women can receive Abrysvo® to protect newborns, while eligible infants can receive Beyfortus®.
Health authorities note that RSV can cause severe lung infections, particularly in older adults and young infants, and can exacerbate chronic conditions. Routine immunizations are strongly encouraged for all Ontarians to prevent illness, reduce hospital visits, and protect public health.
“RSV is a major contributor to illness and hospitalizations. Fortunately, RSV immunization is safe and extraordinarily effective. This vaccine coverage will save lives and help to improve quality of life for older Ontarians by reducing the risk of serious illness and complications. It also will reduce the number of hospitalizations, which means more capacity in our health-care system during the always busy winter season.” – Dr. Chris Simpson, Chief Medical Executive, Ontario Health
The government emphasizes that staying up to date on immunizations is a critical step in safeguarding seniors, infants, and vulnerable populations throughout Ontario this fall and winter. For more information on RSV immunization and where it will be available, residents are encouraged to contact their local public health unit or speak with a health-care provider.
(Written by: Joseph Goden)
